PT2247582T - Forma cristalina anidra do dimetoxidocetaxel e métodos para a preparação do mesmo - Google Patents

Forma cristalina anidra do dimetoxidocetaxel e métodos para a preparação do mesmo

Info

Publication number
PT2247582T
PT2247582T PT97223218T PT09722321T PT2247582T PT 2247582 T PT2247582 T PT 2247582T PT 97223218 T PT97223218 T PT 97223218T PT 09722321 T PT09722321 T PT 09722321T PT 2247582 T PT2247582 T PT 2247582T
Authority
PT
Portugal
Prior art keywords
methods
crystalline form
anhydrous crystalline
preparing same
dimethoxy docetaxel
Prior art date
Application number
PT97223218T
Other languages
English (en)
Inventor
Billot Pascal
Dufraigne Marielle
Elmaleh Hagit
Guiliani Alexandre
Mangin Fabrice
Rortais Patricia
Zaske Lionel
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39712334&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2247582(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PT2247582T publication Critical patent/PT2247582T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT97223218T 2008-01-17 2009-01-15 Forma cristalina anidra do dimetoxidocetaxel e métodos para a preparação do mesmo PT2247582T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0800243A FR2926551A1 (fr) 2008-01-17 2008-01-17 Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation

Publications (1)

Publication Number Publication Date
PT2247582T true PT2247582T (pt) 2016-11-16

Family

ID=39712334

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97223218T PT2247582T (pt) 2008-01-17 2009-01-15 Forma cristalina anidra do dimetoxidocetaxel e métodos para a preparação do mesmo

Country Status (42)

Country Link
US (5) US8378128B2 (pt)
EP (2) EP2247582B1 (pt)
JP (3) JP5932219B2 (pt)
KR (3) KR20150042303A (pt)
CN (3) CN104130220A (pt)
AR (1) AR070175A1 (pt)
AU (1) AU2009227081B2 (pt)
BR (1) BRPI0906518A2 (pt)
CA (1) CA2712373C (pt)
CL (1) CL2009000094A1 (pt)
CO (1) CO6351784A2 (pt)
CR (1) CR11532A (pt)
CY (1) CY1119129T1 (pt)
DK (1) DK2247582T3 (pt)
DO (3) DOP2010000211A (pt)
EA (1) EA017670B1 (pt)
EC (1) ECSP10010324A (pt)
ES (1) ES2606228T3 (pt)
FR (1) FR2926551A1 (pt)
HN (1) HN2010001435A (pt)
HR (1) HRP20161655T1 (pt)
HU (1) HUE032150T2 (pt)
IL (2) IL207031A (pt)
LT (1) LT2247582T (pt)
MA (1) MA32086B1 (pt)
ME (2) ME02694B (pt)
MX (1) MX2010007840A (pt)
MY (1) MY159362A (pt)
NI (4) NI201001033A (pt)
NZ (3) NZ598289A (pt)
PH (1) PH12013500102A1 (pt)
PL (1) PL2247582T3 (pt)
PT (1) PT2247582T (pt)
RS (1) RS55519B1 (pt)
SG (1) SG179446A1 (pt)
SI (1) SI2247582T1 (pt)
TN (1) TN2010000284A1 (pt)
TW (3) TWI477492B (pt)
UA (1) UA105896C2 (pt)
UY (1) UY31602A1 (pt)
WO (1) WO2009115655A2 (pt)
ZA (1) ZA201105206B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2493466B1 (en) 2009-10-29 2021-03-10 Sanofi Mature IP Novel antitumoral use of cabazitaxel
CN103764637A (zh) 2011-04-12 2014-04-30 普拉斯化学品有限公司 卡巴他赛的固态形式及其制备方法
TWI526437B (zh) 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
ES2712804T3 (es) 2011-09-26 2019-05-14 Fresenius Kabi Oncology Ltd Procedimientos para la preparación de carbazitaxel que implican la sililación en C(7)-OH y C(13)-OH o solo la sililación en C(7)-OH
CN102503913B (zh) * 2011-10-20 2014-03-26 江苏红豆杉生物科技股份有限公司 直接用于x射线单晶衍射分析的二甲氧基紫杉烷类化合物单晶晶体的制备方法
DE112012004569T5 (de) 2011-11-01 2014-08-14 Fresenius Kabi Oncology Ltd. Amorphe Form von Cabazitaxel und Verfahren zum Herstellen davon
ES2716799T3 (es) 2011-11-28 2019-06-17 Fresenius Kabi Oncology Ltd Forma cristalina de cabazitaxel y proceso para la preparación de la misma
EP2791122B1 (en) * 2011-12-13 2019-01-23 Aventis Pharma S.A. Crystalline form of cabazitaxel and process for preparing the same
US9403785B2 (en) 2012-01-03 2016-08-02 Shilpa Medicare Limited Process for preparing amorphous cabazitaxel
CN104220431A (zh) * 2012-03-08 2014-12-17 伊瓦克斯国际有限责任公司 卡巴他赛的固态形式及其制备方法
CN102675257B (zh) * 2012-05-10 2014-07-02 上海金和生物技术有限公司 一种卡巴他赛晶体及其制备方法
CN102746258B (zh) * 2012-07-25 2015-02-04 重庆泰濠制药有限公司 卡巴他赛的结晶形式及其制备方法
EP2880021A4 (en) 2012-07-31 2015-06-17 Yung Shin Pharm Ind Co Ltd AMORPHIC CABACITAXEL
WO2014028704A1 (en) 2012-08-15 2014-02-20 Yung Shin Pharm. Ind. Co., Ltd. Stable pharmaceutical formulation of cabazitaxel
CN103664836B (zh) * 2012-09-20 2016-04-20 齐鲁制药有限公司 7β,10β-二甲氧基多西紫杉醇氘代丙酮合物的晶型A及其制备方法
CN102898406B (zh) * 2012-11-02 2014-12-03 上海金和生物技术有限公司 一种卡巴他赛晶体及其制备方法
CN103058960B (zh) * 2012-12-12 2014-12-10 江苏奥赛康药业股份有限公司 卡巴他赛多晶型形式及其制备方法
EP2743264A1 (en) 2012-12-13 2014-06-18 INDENA S.p.A. New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
KR101429543B1 (ko) * 2012-12-13 2014-08-14 주식회사 삼양바이오팜 카바지탁셀의 신규 결정형 및 그 제조방법
CN103910697B (zh) * 2012-12-30 2016-08-03 上海医药工业研究院 卡巴他赛乙酸合物及其结晶
CN103910696B (zh) * 2012-12-30 2016-01-20 上海医药工业研究院 卡巴他赛异丙醚合物及其结晶
CN103910698B (zh) * 2012-12-30 2016-01-20 上海医药工业研究院 卡巴他赛丙酮合物及其结晶
US20150315164A1 (en) * 2012-12-31 2015-11-05 Shilpa Medicare Limited Process for preparing amorphous cabazitaxel
WO2014115168A2 (en) * 2013-01-23 2014-07-31 Leiutis Pharmaceuticals Private Limited Novel solvate forms of cabazitaxel and process for preparation thereof
WO2014128728A2 (en) * 2013-02-25 2014-08-28 Laurus Labs Private Limited Solid forms of cabazitaxel and processes for preparation thereof
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
WO2015000165A1 (zh) * 2013-07-04 2015-01-08 北京新天宇科技开发有限公司 二甲氧基多西紫杉醇一丙酮化物的稳定转化物及其结晶形式、以及它们的制备方法
CN103450119B (zh) * 2013-09-24 2015-06-17 天津炜捷制药有限公司 一种卡巴他赛晶型w及其制备方法
EP2865674A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. Crystalline solvate forms of Cabazitaxel
EP2865675A1 (en) * 2013-10-23 2015-04-29 INDENA S.p.A. A crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN103601704B (zh) * 2013-11-22 2015-05-06 石家庄智恒医药科技有限公司 无定形卡巴他赛的制备
CN104945453B (zh) * 2014-03-28 2018-06-26 江苏天士力帝益药业有限公司 吡唑衍生物的多晶型物
US10188626B2 (en) 2015-11-03 2019-01-29 Cipla Limited Stabilized cabazitaxel formulations
WO2020249507A1 (en) 2019-06-11 2020-12-17 Indena S.P.A. Anhydrous crystalline form of cabazitaxel, a process for its preparation and pharmaceutical compositions containing it

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2163837C (en) * 1994-12-13 1999-07-20 Robert K. Perrone Crystalline paclitaxel hydrates
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US5847170A (en) * 1995-03-27 1998-12-08 Rhone-Poulenc Rorer, S.A. Taxoids, their preparation and pharmaceutical compositions containing them
FR2745814B1 (fr) * 1996-03-06 1998-04-03 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2771092B1 (fr) 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides
US6346543B1 (en) * 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
EP1451168A4 (en) * 2001-11-30 2005-08-24 Bristol Myers Squibb Co PACLITAXELSOLVATE
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
TW200730518A (en) * 2005-10-12 2007-08-16 Sicor Inc Crystalline forms of docetaxel and processes for their preparation
TWI394765B (zh) * 2008-12-12 2013-05-01 Ind Tech Res Inst 難燃水性聚胺基甲酸酯分散液
EP2493466B1 (en) 2009-10-29 2021-03-10 Sanofi Mature IP Novel antitumoral use of cabazitaxel
TWI526437B (zh) 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
ES2716799T3 (es) 2011-11-28 2019-06-17 Fresenius Kabi Oncology Ltd Forma cristalina de cabazitaxel y proceso para la preparación de la misma
EP2791122B1 (en) 2011-12-13 2019-01-23 Aventis Pharma S.A. Crystalline form of cabazitaxel and process for preparing the same

Also Published As

Publication number Publication date
SI2247582T1 (sl) 2017-03-31
CN101918385B (zh) 2014-07-02
US20180002302A1 (en) 2018-01-04
IL207031A (en) 2017-11-30
WO2009115655A3 (fr) 2010-04-01
ECSP10010324A (es) 2010-08-31
SG179446A1 (en) 2012-04-27
HK1150603A1 (en) 2012-01-06
NI201001032A (es) 2011-04-26
US10160739B2 (en) 2018-12-25
JP2014074054A (ja) 2014-04-24
KR20150042303A (ko) 2015-04-20
JP2011509980A (ja) 2011-03-31
TW201444814A (zh) 2014-12-01
NI201001033A (es) 2011-04-26
AU2009227081B2 (en) 2013-11-14
CL2009000094A1 (es) 2010-02-12
NI201000103A (es) 2011-04-26
ME02694B (me) 2017-10-20
US8846959B2 (en) 2014-09-30
AR070175A1 (es) 2010-03-17
CO6351784A2 (es) 2011-12-20
CN104130220A (zh) 2014-11-05
MY159362A (en) 2016-12-30
BRPI0906518A2 (pt) 2015-07-14
TW200944510A (en) 2009-11-01
US20130178639A1 (en) 2013-07-11
CY1119129T1 (el) 2018-02-14
CN104130221A (zh) 2014-11-05
AU2009227081A1 (en) 2009-09-24
DOP2013000016A (es) 2013-06-15
HUE032150T2 (en) 2017-08-28
LT2247582T (lt) 2017-01-25
NZ603797A (en) 2013-05-31
KR20100103614A (ko) 2010-09-27
KR20150042302A (ko) 2015-04-20
RS55519B1 (sr) 2017-05-31
TN2010000284A1 (fr) 2011-11-11
EP2247582A2 (fr) 2010-11-10
PL2247582T3 (pl) 2017-04-28
IL207031A0 (en) 2010-12-30
US20190144406A1 (en) 2019-05-16
DK2247582T3 (da) 2017-01-02
CA2712373A1 (fr) 2009-09-24
HRP20161655T1 (hr) 2017-01-27
UA105896C2 (uk) 2014-07-10
TW201444813A (zh) 2014-12-01
US8378128B2 (en) 2013-02-19
ZA201105206B (en) 2013-05-29
EP2247582B1 (fr) 2016-09-07
NZ586829A (en) 2012-05-25
US20140350272A1 (en) 2014-11-27
CA2712373C (fr) 2016-06-14
IL229239A0 (en) 2013-12-31
NI201001031A (es) 2011-04-26
EA201070856A1 (ru) 2011-02-28
ME01009B (me) 2012-10-20
EA017670B1 (ru) 2013-02-28
FR2926551A1 (fr) 2009-07-24
JP5932219B2 (ja) 2016-06-08
MA32086B1 (fr) 2011-02-01
TWI477492B (zh) 2015-03-21
NZ598289A (en) 2013-06-28
EP2719694A1 (fr) 2014-04-16
CN101918385A (zh) 2010-12-15
MX2010007840A (es) 2010-08-04
ES2606228T3 (es) 2017-03-23
DOP2013000212A (es) 2014-01-31
WO2009115655A2 (fr) 2009-09-24
UY31602A1 (es) 2009-08-31
HN2010001435A (es) 2014-02-03
DOP2010000211A (es) 2010-07-31
CR11532A (es) 2010-11-22
PH12013500102A1 (en) 2015-09-16
JP2015163626A (ja) 2015-09-10
US20110144362A1 (en) 2011-06-16

Similar Documents

Publication Publication Date Title
PL2247582T3 (pl) Postać krystaliczna bezwodna dimetoksydocetakselu i sposoby jej wytwarzania
ZA201106538B (en) Compositions and methods for increasing muscle growth
IL209196A (en) A crystalline form of posaconazole
TWI562775B (en) Methods of using inhibitors of sodium-glucose cotransporters 1 and 2
IL208284A0 (en) Compositions and methods for preparing and using same
EP2483221A4 (en) FERTILIZER COMPOSITIONS AND METHOD THEREFOR
IL219607A0 (en) Compositions and methods for stimulating hair growth
IL233235A0 (en) Devices and methods for increasing bone growth
EP2498988A4 (en) MEDICAL ARTICLES AND METHODS OF MANUFACTURING USING MISCIBLE COMPOSITION
SI3812360T1 (sl) Monoklorotrifluoropropenske spojine in sestavki ter postopki, ki jih uporabljajo
EP2571435A4 (en) BONE ANCHORS
IL206544A0 (en) Methods of preparing quinazolinone derivatives
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
EP2593571A4 (en) SWEETENER COMPOSITIONS AND METHODS OF PRODUCING THE SAME
IL222969A0 (en) Sweetener compositions and methods of preparing the same
ZA201006293B (en) Composition and method for seed treatment use
PT3378930T (pt) Plataforma para a cultura de tecidos in vivo
ZA201300036B (en) Banzamide derivatives and their use as hsp90 inhibitors
IL229968A0 (en) Tetrazolyloxy derivatives and methods for their production
EP2618844A4 (en) ORAL FORMABLE COMPOSITION AND METHOD FOR THEIR PRODUCTION AND USE
ZA201304127B (en) Oral compositions and method for producing thereof
IL218325A0 (en) Methods and compositions for producing plants
EP2358693A4 (en) PREPARATION OF DOCETAXEL
ZA201304126B (en) Oral compositions and method for producing thereof
IL208918A0 (en) Methods of preparing substituted heterocycles-149